Search

Search Constraints

You searched for: Author/Creator Tempero, M

Search Results

1. O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. (2nd July 2019)

2. O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. (2nd July 2019)

4. PD-001Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. (2nd July 2019)